Mode
Text Size
Log in / Sign up

Systematic review and meta-analysis shows adjunctive SVCI reduces AF recurrence but increases minor complications in AF ablationAdding SVCI to AF ablation lowers recurrence but raises minor complication risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider adjunctive SVCI for first-time AF ablation, noting increased minor complications and transient phrenic nerve injury.

This systematic review and meta-analysis of randomized trials assessed the impact of adjunctive superior vena cava isolation (SVCI) plus pulmonary vein isolation (PVI) compared with PVI alone in adults undergoing first-time AF ablation. The study included 1149 participants across the included trials. The primary outcome was atrial tachyarrhythmia recurrence, with secondary outcomes including procedure time, fluoroscopy time, and major and minor complications.

The analysis demonstrated reduced atrial tachyarrhythmia recurrence with the adjunctive approach. For the primary outcome, the odds ratio was 0.71 with a 95% CI of 0.53-0.96. Time-to-event analysis showed a hazard ratio of 0.71 with a 95% CI of 0.50-0.99. In the paroxysmal AF subgroup, the odds ratio was 0.63 with a 95% CI of 0.44-0.88. In the radiofrequency ablation subgroup, the odds ratio was 0.66 with a 95% CI of 0.47-0.93.

Regarding safety, minor complications were increased with the adjunctive approach, with an odds ratio of 4.44 and a 95% CI of 1.95-11.16. The absolute numbers for minor complications were 13.7% versus 2.7%. Major complications were comparable, at 1.8% versus 1.0%. Transient phrenic nerve injury occurred in 6.8% versus 1.4%, and sinus node injury occurred in 1.6% versus 0%. The authors note that the evidence is derived from a meta-analysis of randomized trials and caution against overstatement of certainty.

This systematic review and meta-analysis combined data from randomized trials involving 1,149 adults undergoing their first-time atrial fibrillation ablation. The researchers compared adding adjunctive superior vena cava isolation to standard pulmonary vein isolation against pulmonary vein isolation alone.

The analysis showed that adding the extra isolation step reduced the risk of atrial tachyarrhythmia recurrence. This benefit was seen in the overall group and in specific subgroups, including those with paroxysmal atrial fibrillation and those treated with radiofrequency ablation.

However, the added procedure time and fluoroscopy time were associated with higher rates of minor complications. The rate of major complications remained comparable between the two approaches. Some patients experienced transient phrenic nerve injury or sinus node injury more often with the added step.

Readers should understand that while recurrence rates drop, the trade-off involves more frequent minor issues. This evidence comes from a meta-analysis of randomized trials, which provides a higher level of certainty than observational data, but individual results may vary.

What this means for you:
Adding SVCI to AF ablation reduces recurrence but increases minor complications.

Study Details

Study typeMeta analysis
Sample sizen = 1,149
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Pulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. Nonpulmonary vein triggers, particularly from the superior vena cava, contribute to arrhythmogenesis in a subset of patients. The benefit of adjunctive superior vena cava isolation (SVCI) in addition to PVI remains uncertain. OBJECTIVE: This study aimed to assess the efficacy and safety of adjunctive SVCI in AF ablation. METHODS: We systematically searched PubMed, Embase, and ClinicalTrials.gov for randomized controlled trials comparing adjunctive SVCI plus PVI with PVI alone in adults undergoing first-time AF ablation. The main outcome was atrial tachyarrhythmia recurrence. Additional outcomes included procedure time, fluoroscopy time, and major and minor complications. Pooled odds ratios (ORs), hazard ratios, and 95% confidence intervals (CIs) were calculated using fixed- and random-effects models, with subgroup analyses by AF type and ablation modality. RESULTS: 7 randomized controlled trials involving 1149 patients were included. Adjunctive SVCI to PVI compared with PVI alone was associated with reduced atrial tachyarrhythmia recurrence (OR 0.71; 95% CI 0.53-0.96; I = 0%), confirmed by time-to-event analysis (hazard ratio 0.71; 95% CI 0.50-0.99). The effect was more pronounced in paroxysmal AF (OR 0.63; 95% CI 0.44-0.88) and with radiofrequency ablation (OR 0.66; 95% CI 0.47-0.93). SVCI plus PVI increased minor complications (13.7% vs 2.7%; OR 4.44; 95% CI 1.95-11.16), mainly transient phrenic nerve injury (6.8% vs 1.4%) and sinus node injury (1.6% vs 0%). Major complications were comparable (1.8% vs 1.0%). CONCLUSION: Adjunctive SVCI to PVI vs PVI alone was associated with reduced atrial tachyarrhythmia recurrence but increased minor complications in AF ablation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.